Sulodexide for the extended treatment of venous thromboembolism

Int Angiol. 2016 Dec;35(6):531-533. Epub 2016 Sep 28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Blood Coagulation / drug effects*
  • Glycosaminoglycans / administration & dosage
  • Glycosaminoglycans / adverse effects
  • Glycosaminoglycans / therapeutic use*
  • Hemorrhage / chemically induced
  • Humans
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / drug therapy*
  • Risk Factors
  • Treatment Outcome
  • Venous Thromboembolism / blood
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / drug therapy*
  • Venous Thrombosis / blood
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy*

Substances

  • Anticoagulants
  • Glycosaminoglycans
  • glucuronyl glucosamine glycan sulfate